The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
Open accessAbstract
Aims/hypothesis Insulin resistance, which manifests itself as endogenous glucose overproduction and reduced insulin-mediated glucose uptake, is a core defect in type 2 diabetes. Metformin and the peroxisome proliferator-activated receptor-gamma agonists, the thiazolidinediones (TZDs), both lower glucose, although their mechanism of action is still subject to debate. This review analyses the evidence relevant to these mechanisms in vivo.Materials and methods A systematic search of MEDLINE identified a total of 42 clinical studies that investigated the effects of TZDs (n=23) and/or metformin (n=19) on endogenous glucose production (using tracer glucose techniques) and peripheral glucose disposal (using the euglycaemic-hyperinsulinaemic clamp) in patients with type 2 diabetes (n=549). The original variables assessed were converted into standardised units and their mean group values were listed separately for open and placebo-controlled studies. Statistical analysis was scarried out, treating mean group values as individual values and comparing results (both as absolute values and percentage changes from baseline) across study categories (open vs placebo-controlled, TZDs vs metformin).Results Both TZDs and metformin enhance insulin suppression of endogenous glucose production and fasting plasma glucose clearance. TZDs, but not metformin, also improve insulin-mediated glucose uptake at all insulin levels.Conclusions/interpretation In patients with type 2 diabetes, metformin improves fasting hepatic insulin sensitivity and glucose clearance; TZDs improve fasting hepatic insulin sensitivity and glucose clearance, and potentiate glucose disposal under insulinised conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an increased insulin suppression of endogenous glucose production by the liver(44, 45)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [44]
In the citing paper
“reduction of glucose absorbtion by the gastro-intestinal tract(44, 45)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [44]
In the citing paper
“a decreased in hepatic glucose production by suppression of gluconeogenesis(44, 45)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B. H., Beerdsen, P., Joyce, M., & Olefsky, J. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 914
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898 · cited 1×
“concentrations (European Group for the study of Insulin Resistance [EGIR] database [18]).”
BackgroundSelf-citationEfficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794
International Textbook of Diabetes Mellitus
(2003) · Wiley eBooks · doi:10.1002/0470862092 · Cited by 744
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 536
The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488
Hundal, R. S., & Inzucchi, S. E. (2003) · Drugs · doi:10.2165/00003495-200363180-00001 · Cited by 315
Schernthaner, G., Matthews, D. R., Charbonnel, B. H., Hanefeld, M., & Brunetti, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030861 · Cited by 267
Mechanisms of Early Insulin-Sensitizing Effects of Thiazolidinediones in Type 2 Diabetes
Tonelli, J., Li, W., Kishore, P., Pajvani, U. B., Kwon, E., Weaver, C. L., Scherer, P. E., & Hawkins, M. A. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1621 · Cited by 247
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 379
Jacob, S., Dötsch, A., Knoll, S., Köhler, H., Rogall, E. T., Stoll, D., Tisler, S., Hühn, C., Schwartz, T., Zwiener, C., et al. (2018) · Environmental Sciences Europe · doi:10.1186/s12302-018-0179-4 · Cited by 49
Mechanisms of action of metformin and its regulatory effect on microRNAs related to angiogenesis
Wang, G., Lin, F., Wan, Q., Wu, J., & Luo, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105390 · Cited by 45
NIRANJAN, S., Phillips, B. E., & Giannoukakis, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193373 · Cited by 44
Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice
Alderman, J. M., Flurkey, K., Brooks, N. L., Naik, S. B., Gutierrez, J. M., Srinivas, U., Ziara, K. B., Jing, L., Boysen, G., Bronson, R. T., et al. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.014 · Cited by 44
Memon, H., Abdulla, F., Reljic, T., Alnuaimi, S., Serdarević, F., Velija-Ašimi, Z., Kumar, A., & Semiz, S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110806 · Cited by 43
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 43
Liu, S.-C., Chien, K., Wang, C., Chen, W.-C., & Cleunghen, C.-H. (2013) · Endocrine Practice · doi:10.4158/ep13148.or · Cited by 40
Mühlhäusler, B. S., Morrison, J. L., & McMillen, I. C. (2009) · Endocrinology · doi:10.1210/en.2009-0462 · Cited by 40
Shawky, N. M., Shehatou, G. S. G., Suddek, G. M., & Gameil, N. M. (2018) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2018.12.008 · Cited by 38
Ansari, P., Flatt, P. R., Harriott, P., & Abdel‐Wahab, Y. H. A. (2020) · Plants · doi:10.3390/plants9101348 · Cited by 44
Susilawati, E., Levita, J., Susilawati, Y., & Sumiwi, S. A. (2023) · Medical Sciences · doi:10.3390/medsci11030050 · Cited by 38
Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
Bianchi, C., Daniele, G., Dardano, A., Miccoli, R., & Prato, S. D. (2017) · Drugs · doi:10.1007/s40265-017-0694-4 · Cited by 41
AMPK inhibits liver gluconeogenesis: fact or fiction?
Johanns, M., Hue, L., & Rider, M. H. (2023) · Biochemical Journal · doi:10.1042/bcj20220582 · Cited by 46
Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes
Tahrani, A. A., & Barnett, A. H. (2010) · Diabetes Therapy · doi:10.1007/s13300-010-0007-3 · Cited by 37
Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update
Sarafidis, P. A. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00568.x · Cited by 36
Abolhassani, N., Winterfeld, U., Kaplan, Y. C., Jaques, C., Minder, B., Giovane, C. D., & Panchaud, A. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002919 · Cited by 37
Type 2 diabetes: A well-characterised but suboptimally controlled disease. Can we bridge the divide?
Monnier, L., Colette, C., & Owens, D. R. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.01.011 · Cited by 37
Combined Therapy With Insulin Plus Oral Agents: Is There Any Advantage?
Riddle, M. C. (2008) · Diabetes Care · doi:10.2337/dc08-s231 · Cited by 34
Dubayee, M. S. A., Alayed, H., Almansour, R., Alqaoud, N., Alnamlah, R., Obeid, D., Alshahrani, A. S., Zhra, M., Nasr, A., Al-Bawab, A., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00537 · Cited by 36
Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review
Noh, R. M., Graveling, A. J., & Frier, B. M. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.589835 · Cited by 36
Armato, J., DeFronzo, R. A., Abdul-Ghani, M., & Ruby, R. (2012) · Endocrine Practice · doi:10.4158/ep11194.or · Cited by 35
Schernthaner, G., Schernthaner-Reiter, M. H., & Schernthaner, G.-H. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.04.037 · Cited by 38
Metformin, a biological and synthetic overview
Hernández‐Velázquez, E. D., Betancourt, C. A., Alonso‐Castro, Á. J., Ortíz‐Alvarado, R., López, J. A., Carmen, V. M., & Solorio‐Alvarado, C. R. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129241 · Cited by 36
Moonira, T., Chachra, S. S., Ford, B. E., Marín, S., Alshawi, A., Adam-Primus, N. S., Arden, C., Al‐Oanzi, Z. H., Foretz, M., Viollet, B., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012533 · Cited by 35
Metformin Biodistribution: A Key to Mechanisms of Action?
Sundelin, E. I. O., Jensen, J., Jakobsen, S., Gormsen, L. C., & Jessen, N. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa332 · Cited by 34
Almatroodi, S. A., Alnuqaydan, A. M., Alsahli, M. A., Khan, A. A., & Rahmani, A. H. (2021) · Applied Sciences · doi:10.3390/app11073223 · Cited by 34
Fructose-1,6-bisphosphatase as a therapeutic target for type 2 diabetes
van Poelje, P. D., Dang, Q., & Erion, M. D. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.10.003 · Cited by 34
Raskin, P. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.783 · Cited by 33
In Vitro and In Vivo Antioxidant and Anti-Hyperglycemic Activities of Moroccan Oat Cultivars
Marmouzi, I., Karym, E. M., Saïdi, N., Meddah, B., Kharbach, M., Masrar, A., Bouabdellah, M., Chabraoui, L., Allali, K. E., Cherrah, Y., et al. (2017) · Antioxidants · doi:10.3390/antiox6040102 · Cited by 34
Eckstein, M. L., Williams, D. M., O'Neil, L., Hayes, J., Stephens, J. W., & Bracken, R. M. (2018) · Diabetic Medicine · doi:10.1111/dme.13865 · Cited by 34
Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect
Dhanesha, N., Joharapurkar, A. A., Shah, G. B., Dhote, V. V., Kshirsagar, S. G., Bahekar, R. H., & Jain, M. R. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70740-5 · Cited by 33
Synthesis and anti-hyperglycemic activity of hesperidin derivatives
Zhang, B., Chen, T., Chen, Z., Wang, M., Zheng, D., Wu, J., Jiang, X., & Li, X. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.049 · Cited by 33
Pearson, E. R. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0028-3 · Cited by 31
Metformin - its anti-cancer effects in hematologic malignancies
Podhorecka, M. (2021) · Oncology Reviews · doi:10.4081/oncol.2021.514 · Cited by 32
Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Zhang, Y., Zhou, F., Guan, J., Zhou, L., & Chen, B. (2023) · Biomolecules · doi:10.3390/biom13020250 · Cited by 38
Tong, L., & Adler, S. G. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1457397 · Cited by 36
Okamoto, T., Kanemoto, N., Ban, T., Sudo, T., Nagano, K., & Niki, I. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.015 · Cited by 31
Takada, J., Fonseca‐Alaniz, M. H., de Campos, T. B. F., Andreotti, S., Campaña, A. B., Okamoto, M. M., Borges‐Silva, C. N., Machado, U. F., & Lima, F. B. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0072 · Cited by 30
Tan, M. H., Alquraini, H., Mizokami‐Stout, K., & MacEachern, M. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.008 · Cited by 33
Udhane, S. S., Legeza, B., Marti, N., Hertig, D., Diserens, G., Nuoffer, J., Vermathen, P., & Flück, C. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-09189-y · Cited by 31
The Effect of Metformin on Glucose Homeostasis During Moderate Exercise
Hansen, M., Palsøe, M. K., Helge, J. W., & Dela, F. (2014) · Diabetes Care · doi:10.2337/dc14-1480 · Cited by 31
Pharmacotherapy of Diabetes: New Developments
Mogensen, C. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6 · Cited by 30
Shen, N., Jiang, S., Lu, J., Yu, X., Lai, S., Zhang, J., Zhang, J.-L., Tao, W.-W., Wang, X., Xu, N., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.10.016 · Cited by 32
Virtual metabolic human dynamic model for pathological analysis and therapy design for diabetes
Kurata, H. (2021) · iScience · doi:10.1016/j.isci.2021.102101 · Cited by 26
Metformin as a Potential Treatment Option for Endometriosis
Kimber-Trojnar, Ż., Dłuski, D. F., Wierzchowska-Opoka, M., Ruszała, M., & Leszczyńska‐Gorzelak, B. (2022) · Cancers · doi:10.3390/cancers14030577 · Cited by 32
Morsy, M. A., Ashour, O. M., Fouad, A. A., & Abdel-Gaber, S. A. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05250.x · Cited by 29
Lin, J., Chen, H., Chiu, C., & Liang, Y. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.922951 · Cited by 27
Steinberg, G. R. (2018) · Diabetes · doi:10.2337/dbi17-0039 · Cited by 29
Triplitt, C. L., Glass, L. C., Miyazaki, Y., Wajcberg, E., Gastaldelli, A., Filippis, E. D., Cersósimo, E., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-0564 · Cited by 28
Prevention and Treatment of Type 2 Diabetes: A Pathophysiological-Based Approach
Samocha‐Bonet, D., Debs, S. R., & Greenfield, J. R. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.03.014 · Cited by 26
The Hormetic Effect of Metformin: “Less Is More”?
Panfoli, I., Puddu, A., Bertola, N., Ravera, S., & Maggi, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126297 · Cited by 29
The double trouble of metabolic diseases: the diabetes–cancer link
Tudzarova, S., & Osman, M. A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-11-1550 · Cited by 26
Tamura, Y., Watada, H., Sato, F., Kumashiro, N., Sakurai, Y., Hirose, T., Tanaka, Y., & Kawamori, R. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00801.x · Cited by 26
Tanaka, M., Saito, Y., Misu, H., Kato, S., Kita, Y., Takeshita, Y., Kanamori, T., Nagano, T., Nakagen, M., Urabe, T., et al. (2014) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21824 · Cited by 25
Pilmark, N. S., Lyngbæk, M. P. P., Oberholzer, L., Elkjær, I., Petersen-Bønding, C., Kofoed, K., Siebenmann, C., Kellenberger, K., van Hall, G., Abildgaard, J., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05282-6 · Cited by 26
Characterization of STZ-Induced Type 2 Diabetes in Zucker Fatty Rats
Okamoto, T., KANEMOTO, N., Ohbuchi, Y., Okano, M., Fukui, H., & Sudo, T. (2008) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.57.335 · Cited by 25
Vikram, A., Jena, G., & Ramarao, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00994.x · Cited by 24
Toledo, F. G. S., Miller, R. G., Helbling, N. L., Zhang, Y., & DeLany, J. P. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14333 · Cited by 24
Serlie, M. J. M., Allick, G., Groener, J. E. M., Ackermans, M. T., Heijligenberg, R., Voermans, B. C., Aerts, J. M. F. G., Meijer, A. J., & Sauerwein, H. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1518 · Cited by 24
What are the pharmacotherapy options for treating prediabetes?
Daniele, G., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944160 · Cited by 23
Zeynaloo, E., Stone, L. D., Dikici, E., Ricordi, C., Deo, S. K., Bachas, L. G., Daunert, S., & Lanzoni, G. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101063 · Cited by 23
Prevention and treatment of nonalcoholic fatty liver disease
Targher, G., Bellis, A., Fornengo, P., Ciaravella, M. F., Pichiri, I., Perin, P. C., Trimarco, B., & Marchesini, G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.02.004 · Cited by 23
Hepatic function and the cardiometabolic syndrome
Wiernsperger, N. F. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s51145 · Cited by 26
Glucose Uptake and Insulin Response in Tissue-engineered Human Skeletal Muscle
Kondash, M. E., Ananthakumar, A., Khodabukus, A., Bursac, N., & Truskey, G. A. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00242-y · Cited by 24
Review: Advances in the treatment of nonalcoholic fatty liver disease
Mehta, S. R. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810379587 · Cited by 24
Prevention of diabetes: a strategic approach for individual patients
Shin, J., Lee, J., Kim, H., Choi, Y., Cho, J., & Yoon, K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2357 · Cited by 22
Pharmacogenetics and future strategies in treating hyperglycaemia in diabetes
Ewan, R. P. (2009) · Frontiers in bioscience · doi:10.2741/3532 · Cited by 21
Thiazolidinedione derivatives in type 2 diabetes mellitus.
Tack, C. J., & Smits, P. (2006) · PubMed · Cited by 22
Glucose plus metformin compared with glucose alone on β-cell function in mouse pancreatic islets
HASHEMITABAR, M., BAHRAMZADEH, S., SAREMY, S., & NEJADDEHBASHI, F. (2015) · Biomedical Reports · doi:10.3892/br.2015.476 · Cited by 21
Decreased incidence of diabetes in patients with gout using benzbromarone
Niu, S., Chang, K., TA, A., Chang, Y.-H., Kuo, I., Hung, C., Chiu, Y., Hwang, S., Lin, S.-F., & Lin, H. Y. (2018) · Rheumatology · doi:10.1093/rheumatology/key138 · Cited by 22
Mengozzi, A., Tricò, D., Nesti, L., Petrie, J. R., Højlund, K., Mitrakou, A., Krebs, M., Mari, A., & Natali, A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154185 · Cited by 21
Self-citationQuantifying rates of glucose production in vivo following an intraperitoneal tracer bolus
Wang, S., Zhou, D., Yao, Z., Satapati, S., Chen, Y., Daurio, N. A., Petrov, A., Shen, X., Metzger, D., Wu, Y., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00182.2016 · Cited by 20
Elattar, S., Estaphan, S., Mohamed, E., Elzainy, A., & Naguib, M. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.11.012 · Cited by 20
Janjusevic, M., Fluca, A. L., Gagno, G., Pierri, A., Padoan, L., Sorrentino, A., Beltrami, A. P., Sinagra, G., & Aleksova, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042336 · Cited by 21
Mitchell, P. L., Nachbar, R. T., Lachance, D., St‐Pierre, P., Trottier, J., Barbier, O., & Marette, A. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12818 · Cited by 19
Prato, S. D., & CHILTON, R. J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13169 · Cited by 19
Jacob, S., Köhler, H., Tisler, S., Zwiener, C., & Triebskorn, R. (2019) · Frontiers in Environmental Science · doi:10.3389/fenvs.2019.00045 · Cited by 22
Dorkhan, M., Frid, A. H., & Groop, L. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.009 · Cited by 19
Molecular action and pharmacogenetics of metformin: current understanding of an old drug
Rena, G., Pearson, E. R., & Sakamoto, K. (2012) · Diabetes Management · doi:10.2217/dmt.12.42 · Cited by 19
Iliadis, F. S., Kadoglou, N. P. E., Hatzitolios, A. I., Karamouzis, M. V., Alevizos, M., & Karamitsos, D. T. (2007) · PubMed · Cited by 18
The development and benefits of metformin in various diseases
Dong, Y., Qi, Y., Jiang, H., Tian, M., Zhang, Y., Peng, C. S., Li, W.-C., Zhang, Y., Zhou, Y., Zang, Y., et al. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0998-6 · Cited by 21
Treatment of type 2 diabetes mellitus in the elderly – Special considerations
Gadó, K., Tabák, Á. G., Vingender, I., Domján, G., & Dörnyei, G. (2024) · Physiology International · doi:10.1556/2060.2024.00317 · Cited by 24
Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes
Basu, R., Basu, A., Chandramouli, V., Norby, B., Dicke, B. A., Shah, P. J., Cohen, O., Landau, B. R., & Rizza, R. A. (2008) · Diabetologia · doi:10.1007/s00125-008-1138-1 · Cited by 17
A fixed-dose combination of pioglitazone and metformin:a promising alternative in metabolic control
Seufert, J. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x121002 · Cited by 18
Larsen, A. H., Wiggers, H., Dollerup, O. L., Jespersen, N. R., Hansson, N. H., Frøkiær, J., Brøsen, K., Nørrelund, H., Bøtker, H. E., Møller, N., et al. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07050-5 · Cited by 17
A Review on Metformin: Clinical Significance and Side Effects
Mazumder, A., & Ashini, S. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.01070 · Cited by 22
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Thomas, C., Wurzer, L., Malle, E., Ristow, M., & Madreiter‐Sokolowski, C. T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.905261 · Cited by 18
Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control
Sebo, Z. L., Chakrabarty, R. P., Grant, R. A., D’Alessandro, K. B., Koss, A., Blum, J. L. E., Davidson, S. M., Reczek, C. R., & Chandel, N. S. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01530-y · Cited by 21
GLP-1 receptor agonists in the treatment of Type 2 diabetes
Åhrén, B. (2013) · Diabetes Management · doi:10.2217/dmt.13.41 · Cited by 16
Management of Hyperglycemia in Older Adults with Type 2 Diabetes
Gandhi, G. Y., & Mooradian, A. D. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00910-1 · Cited by 18
Reading, C. L., Stickney, D. R., Flores-Riveros, J. R., Destiche, D. A., Ahlem, C. N., Cefalu, W. T., & Frincke, J. M. (2013) · Obesity · doi:10.1002/oby.20207 · Cited by 16
Xiao, X., Erukainure, O. L., Sanni, O., Koorbanally, N. A., & Islam, M. S. (2020) · Journal of Food Science and Technology · doi:10.1007/s13197-020-04471-w · Cited by 16
Miceli, D. D., Vidal, P. N., Blatter, M. F. C., Pignataro, O. P., & Castillo, V. A. (2018) · Open Veterinary Journal · doi:10.4314/ovj.v8i2.13 · Cited by 15
A blast from the past: To tame time with metformin
Xenos, D., Mecocci, P., & Boccardi, V. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111743 · Cited by 15
Metformin and bladder cancer: Drug repurposing as a potential tool for novel therapy: A review
Feng, Y., Jia, B., & Shen, Z. (2022) · Medicine · doi:10.1097/md.0000000000031635 · Cited by 15
Wang, C.-P., Chung, F., Shin, S., & Lee, Y. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.77 · Cited by 15
Jenkins, Y., Sun, T., Li, Y., Markovtsov, V. V., Uy, G., Groß, L., Goff, D. A., Shaw, S. J., Boralsky, L. A., Singh, R., et al. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-674 · Cited by 14
Giuseppe, G. D., Ciccarelli, G., CEFALO, C. M. A., Cinti, F., Moffa, S., Impronta, F., Capece, U., Pontecorvi, A., Giaccari, A., & Mezza, T. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03405-9 · Cited by 17
Oróstica, M. L., Astorga, I., Plaza-Parrochia, F., Poblete, C., Carvajal, R., García, V., Romero, C., & Vega, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073922 · Cited by 16
Fard, A. A., Hajrezaie, M., Kadir, F. A., Sefideh, F. A., Salama, S. M., Alnajar, Z. A. A., Qader, S. W., Alshawsh, M. A., & Abdulla, M. A. (2011) · Molecules · doi:10.3390/molecules16119534 · Cited by 14
Metadata
- Authors
- Natali, A., & Ferrannini, E.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Ferrannini, E.
- ORCID
- Natali, A.
- Venue
- Diabetologia
- Published
- 2006-02-14
- Volume
- 49
- Issue
- 3
- Pages
- 434-441
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2123472586
- Cited by
- 377
- References
- 32
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 5 · 2023: 27 · 2022: 24 · 2021: 27 · 2020: 23 · 2019: 22 · 2018: 25 · 2017: 23 · 2016: 20 · 2015: 20 · 2014: 13 · 2013: 27 · 2012: 17
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- metformin, thiazolidinediones, type 2 diabetes, hepatic glucose production, insulin resistance, glucose uptake, insulin sensitivity, glucose clearance, peroxisome proliferator-activated receptor gamma agonists, insulin-stimulated glucose disposal
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Glucose, Humans, Liver, Metformin, Thiazolidinediones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
